US Patent Issued to EYEPOINT PHARMACEUTICALS on Feb. 10 for "Methods of treating acute respiratory distress syndrome with activators of Tie-2" (Ohio Inventor)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,362, issued on Feb. 10, was assigned to EYEPOINT PHARMACEUTICALS INC. (Watertown, Mass.).

"Methods of treating acute respiratory distress syndrome with activators of Tie-2" was invented by Kevin Peters (Cincinnati).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for treating acute respiratory distress syndrome, lung injury, respiratory failure, and associated conditions using activators of Tie-2 and inhibitors of HPTPBeta. The methods include reducing vascular leak and permeability, reducing edema, reducing inflammation, and increasing oxygen exchange capacity in the lungs."

The patent was filed on May 20, 2021, under App...